Citius Pharmaceuticals, Inc. (CTXR) Operating income 2016–2025
Citius Pharmaceuticals, Inc. (CTXR) annual operating income history from SEC filings — each fiscal year as reported.
-$38.5MFY2025 · since FY2016: -$7.4M → -$38.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.5M | +8.3% |
| FY2024 | -$42.0M | -14.3% |
| FY2023 | -$36.7M | -10.3% |
| FY2022 | -$33.3M | -41.6% |
| FY2021 | -$23.5M | -32.9% |
| FY2020 | -$17.7M | -13.5% |
| FY2019 | -$15.6M | -13.1% |
| FY2018 | -$13.8M | -38.1% |
| FY2017 | -$10.0M | -34.1% |
| FY2016 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice